4//SEC Filing
Molineaux Christopher P. 4
Accession 0001209191-23-038409
CIK 0001557746other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:31 PM ET
Size
11.0 KB
Accession
0001209191-23-038409
Insider Transaction Report
Form 4
Molineaux Christopher P.
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-15$1.52/sh+198$301→ 32,003 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-15−51→ 0 totalExercise: $0.72Exp: 2024-08-12→ Common Stock (51 underlying) - Exercise/Conversion
Common Stock
2023-06-15$0.72/sh+51$37→ 31,805 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-15−198→ 0 totalExercise: $1.52Exp: 2024-12-07→ Common Stock (198 underlying)
Footnotes (2)
- [F1]25% of the shares underlying this option vested on August 13, 2015 and the remaining shares vested in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date.
- [F2]25% of the shares underlying this option vested on December 8, 2015 and the remaining shares vested in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the Issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654773
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:31 PM ET
- Size
- 11.0 KB